⌑ I · The MechanismHow it actually works.
Testosterone is the primary androgen in males, synthesized predominantly in the Leydig cells of the testes (~95%) with smaller contributions from the adrenal cortex. Production is regulated by the hypothalamic-pituitary-gonadal (HPG) axis: the hypothalamus releases GnRH, which signals the pituitary to release LH and FSH, which signal the testes to produce testosterone. The system is governed by negative feedback — circulating testosterone signals the hypothalamus and pituitary to reduce GnRH/LH output, maintaining homeostasis.[1]
In circulation, testosterone exists in three forms: free (~2%, bioactive), albumin-bound (~30%, weakly bound and accessible), and SHBG-bound (~68%, tightly bound and inactive). The bioactive fraction binds androgen receptors throughout the body — muscle, brain, bone, skin, reproductive tissues — producing the well-known effects on protein synthesis, libido, mood, cognition, bone density, and red blood cell production.[1]
Testosterone is also converted enzymatically to two downstream hormones: dihydrotestosterone (DHT) via 5-alpha reductase (responsible for scalp hair loss, prostate effects, and stronger androgenic signaling), and estradiol (E2) via aromatase (responsible for bone health and certain CNS effects). The balance of these conversions matters substantially in clinical management.[1]
Testosterone level is not a single number; it is a system. Total testosterone, free testosterone, SHBG, E2, LH, and FSH together describe what's actually happening. Many "low T" complaints come from elevated SHBG (binding up free T despite normal total) or suppressed LH (signaling primary vs secondary cause). A complete panel is the floor for any meaningful intervention.
⌑ II · The EvidenceWhat the research actually shows.
The data on testosterone falls into three distinct categories: (1) effects of optimization through lifestyle, (2) effects of testosterone replacement therapy (TRT) in diagnosed hypogonadism, and (3) effects of supraphysiological dosing for performance.
- Age-related decline. The Baltimore Longitudinal Study of Aging documented age-related testosterone decline of ~1-2% per year after age 30 in healthy men. By age 70, ~30% of men meet diagnostic criteria for hypogonadism (total T < 300 ng/dL with symptoms).[2]
- Sleep and testosterone. Leproult and Van Cauter (2011) demonstrated that one week of sleep restriction (5 hr/night) reduced total testosterone by 10-15% in healthy young men — equivalent to 10-15 years of normal aging in seven days.[3]
- Body composition. Visceral adipose tissue is the most powerful aromatase site in the male body, converting testosterone to estradiol and lowering serum T. Camacho et al. (2013, European Male Aging Study) found that obesity was a stronger predictor of low testosterone than chronological age.[4]
- TRT outcomes (in hypogonadism). The TRAVERSE trial (Lincoff et al. 2023, NEJM, n=5,246) is the largest cardiovascular safety RCT to date. Testosterone replacement to mid-normal range in men with confirmed hypogonadism did NOT increase major adverse cardiovascular events vs. placebo over a mean 22-month follow-up — a meaningful resolution of previously contested safety data.[5]
- TRT body composition effects. Bhasin et al. (1996, NEJM) demonstrated dose-dependent increases in fat-free mass and strength with testosterone administration, in both trained and untrained men. Supraphysiological doses (600 mg/wk) added 6 kg of fat-free mass over 10 weeks without training.[6]
- Vitamin D and testosterone. Pilz et al. (2011) found that 3,332 IU/day vitamin D3 for one year increased total testosterone significantly in men with baseline vitamin D deficiency. Effect repletion-dependent. See the D3 protocol →[7]
⌑ III · OptimizationHow to actually improve it (without TRT).
Sleep
The single highest-leverage lever. Target 7-9 hours per night with stable timing. Sleep apnea, if present, dramatically suppresses morning testosterone — treatment of OSA can normalize levels.[3]
Body composition
Reducing visceral adiposity reduces aromatization and raises serum testosterone. A meta-analysis by Corona et al. (2013) found that meaningful weight loss (> 5% body weight) increased total testosterone by ~84 ng/dL on average in obese men.[8]
Resistance training
Acute testosterone response to resistance training is modest and transient. The chronic effect on serum testosterone is small. However, increased lean mass and reduced fat mass via training produces sustained downstream improvements in T levels.
Vitamin D + zinc + magnesium
If deficient in any of these, repletion supports endogenous testosterone production. NOT supraphysiological boosting — corrective. Supplementing these without underlying deficiency produces no testosterone benefit.[7]
Alcohol and stress
Chronic alcohol intake suppresses testosterone through multiple mechanisms (testicular damage, increased aromatization, cortisol elevation). Chronic psychological stress and elevated cortisol suppress LH and reduce free T. Both modifiable.
⌑ IV · TRTWhen supplementation is medically indicated.
The Endocrine Society's 2018 clinical practice guideline defines hypogonadism as both: (1) consistent symptoms (low libido, erectile dysfunction, fatigue, depressed mood, loss of body hair, reduced muscle mass), AND (2) total testosterone below the established reference range on at least two morning measurements.[1]
Standard testosterone replacement regimens
- Testosterone cypionate / enanthate IM or subcutaneous: 100-200 mg/week, often split into twice-weekly doses for more stable serum levels
- Testosterone gel (transdermal): 5-10 g daily, applied to shoulders/upper arms
- Testosterone pellets: implanted every 3-6 months, slow-release
- Oral testosterone undecanoate: newer formulation, twice-daily with food
Goal
Restore serum total testosterone to the mid-normal range (~500-700 ng/dL trough), resolve symptoms, while monitoring estradiol, hematocrit, PSA, and lipid response.[1]
Monitoring
Initial follow-up at 3-6 months, then annually. Required labs: total T, free T, SHBG, estradiol, hematocrit, PSA (over 40), comprehensive metabolic panel, lipid panel.[1]
Fertility consideration
Exogenous testosterone suppresses LH and FSH, which in turn suppresses spermatogenesis. Men desiring fertility should discuss alternatives like hCG, enclomiphene, or combined protocols with a urologist or reproductive endocrinologist before initiating TRT.[1]
TRT requires diagnosis, monitoring, and dose adjustment by a qualified physician. Self-administration without monitoring carries real risks: erythrocytosis (elevated hematocrit), unmanaged estradiol elevation, prostate effects, infertility, and (with poorly sourced compounds) contamination and dosing errors. This Codex describes what the medical literature documents — it does not constitute medical advice or a recommendation to self-administer.
⌑ V · ConsiderationsWhat to watch for.
- Erythrocytosis. Most common TRT side effect. Hematocrit > 54% increases thrombotic risk; managed with dose reduction or therapeutic phlebotomy.[1]
- Estradiol management. Aromatase inhibitors (anastrozole) suppress E2; aggressive suppression causes joint pain, lipid derangement, and reduced libido. Most TRT patients do best with E2 in normal male reference range, not suppressed.[1]
- Sleep apnea. Untreated OSA can worsen with TRT. Screen and treat first.[1]
- Prostate considerations. Current evidence does not support TRT causing prostate cancer, but pre-existing untreated prostate cancer is a contraindication. Baseline PSA and DRE prior to initiation in men over 40.[1]
- Cardiovascular history. Pre-TRAVERSE data raised concerns; TRAVERSE largely resolved them but did not exonerate completely. Men with recent MI, stroke, or unstable cardiovascular disease require careful evaluation.[5]
⌑ VI · Related CompoundsThe expanding toolkit.
- hCG (human chorionic gonadotropin). Mimics LH, maintains testicular function and fertility during TRT. Often used adjunctively at 250-500 IU 2-3x/week.
- Enclomiphene. Selective estrogen receptor modulator (SERM) that increases endogenous LH/FSH. Used as a fertility-preserving alternative to TRT in some primary hypogonadism cases.
- Anastrozole. Aromatase inhibitor used when estradiol elevation becomes problematic. Conservative dosing — over-suppression is more common than under-suppression in practice.
- Tongkat Ali (Eurycoma longifolia). Modest evidence for raising endogenous T in hypogonadal men. Effect size small; emerging research.